Arrowstreet Capital, Limited Partnership Novo Nordisk A S Transaction History

Arrowstreet Capital, Limited Partnership

$114 Billion
Q2 2024

A detailed history of Arrowstreet Capital, Limited Partnership transactions in Novo Nordisk A S stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 395,898 shares of NVO stock, worth $53.4 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

395,898

Holding current value

$53.4 Million

% of portfolio

0.05%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$122.71 - $146.91 $48.6 Million - $58.2 Million	395,898 New	395,898 $56.5 Million
Q4 2023 Feb 14, 2024	SELL	$87.78 - $105.45 $59.9 Million - $72 Million	-682,356 Reduced 53.17%	601,007 $62.2 Million
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $88.4 Million - $194 Million	972,122 Added 312.34%	1,283,363 $117 Million
Q2 2023 Aug 14, 2023	BUY	$155.98 - $172.65 $33.4 Million - $37 Million	214,030 Added 220.17%	311,241 $50.4 Million
Q1 2023 May 15, 2023	BUY	$132.34 - $159.14 $11.4 Million - $13.8 Million	86,491 Added 806.82%	97,211 $15.5 Million
Q4 2022 Feb 14, 2023	SELL	$102.55 - $135.33 $1.7 Million - $2.25 Million	-16,619 Reduced 60.79%	10,720 $1.45 Million
Q3 2022 Nov 14, 2022	SELL	$95.28 - $116.93 $165 Million - $203 Million	-1,735,031 Reduced 98.45%	27,339 $2.72 Million
Q2 2022 Aug 15, 2022	BUY	$103.24 - $121.81 $49.2 Million - $58 Million	476,258 Added 37.03%	1,762,370 $196 Million
Q1 2022 May 13, 2022	BUY	$93.1 - $112.54 $33.9 Million - $41 Million	364,372 Added 39.53%	1,286,112 $143 Million
Q4 2021 Feb 14, 2022	BUY	$95.88 - $117.08 $51.2 Million - $62.5 Million	533,804 Added 137.6%	921,740 $103 Million
Q3 2021 Nov 12, 2021	BUY	$84.42 - $106.62 $32.7 Million - $41.4 Million	387,936 New	387,936 $37.2 Million
Q1 2021 May 14, 2021	SELL	$67.06 - $75.82 $44.7 Million - $50.5 Million	-666,342 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$63.89 - $73.8 $37 Million - $42.8 Million	-579,693 Reduced 46.52%	666,342 $46.5 Million
Q3 2020 Nov 12, 2020	SELL	$63.69 - $70.22 $115 Million - $127 Million	-1,812,062 Reduced 59.25%	1,246,035 $86.5 Million
Q2 2020 Aug 12, 2020	SELL	$58.54 - $67.94 $48.4 Million - $56.2 Million	-826,889 Reduced 21.28%	3,058,097 $200 Million
Q1 2020 May 15, 2020	SELL	$49.46 - $64.78 $5.38 Million - $7.04 Million	-108,734 Reduced 2.72%	3,884,986 $234 Million
Q4 2019 Feb 13, 2020	SELL	$49.86 - $58.26 $9.03 Million - $10.5 Million	-181,011 Reduced 4.34%	3,993,720 $231 Million
Q3 2019 Nov 14, 2019	SELL	$47.54 - $53.43 $7.37 Million - $8.28 Million	-155,037 Reduced 3.58%	4,174,731 $216 Million
Q2 2019 Aug 14, 2019	SELL	$46.79 - $52.47 $92.6 Million - $104 Million	-1,978,797 Reduced 31.37%	4,329,768 $221 Million
Q1 2019 May 15, 2019	SELL	$46.36 - $52.63 $12.6 Million - $14.4 Million	-272,798 Reduced 4.15%	6,308,565 $330 Million
Q4 2018 Feb 14, 2019	BUY	$41.54 - $47.25 $176 Million - $200 Million	4,240,464 Added 181.15%	6,581,363 $303 Million
Q3 2018 Nov 14, 2018	SELL	$46.76 - $51.24 $27 Million - $29.6 Million	-578,151 Reduced 19.81%	2,340,899 $110 Million
Q2 2018 Aug 14, 2018	BUY	$44.29 - $50.42 $31.1 Million - $35.4 Million	701,210 Added 31.62%	2,919,050 $135 Million
Q1 2018 May 14, 2018	SELL	$48.49 - $58.14 $16.2 Million - $19.4 Million	-334,404 Reduced 13.1%	2,217,840 $109 Million
Q4 2017 Feb 09, 2018	BUY	$47.53 - $53.73 $93.8 Million - $106 Million	1,974,129 Added 341.48%	2,552,244 $137 Million
Q3 2017 Nov 14, 2017	BUY	$41.15 - $49.22 $23.8 Million - $28.5 Million	578,115	578,115 $27.8 Million

Others Institutions Holding NVO

# of Institutions

1,991

Shares Held

318M

Call Options Held

5.23M

Put Options Held

4.97M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $304B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.

Account

Arrowstreet Capital, Limited Partnership Novo Nordisk A S Transaction History